Point-of-care processing is a safe and efficient way to treat patients requiring autologous regenerative therapies. We have come to appreciate the fact that most patients will benefit from point-of-care processing in a physician’s office or outpatient surgical center. With this in mind EmCyte Corporation has developed the GenesisCS MINI Component Concentrating System. Utilizing 30ml separator tubes and a smaller custom performance centrifuge system, the GenesisCS MINI has become the hallmark of a true point-of-care low volume system.  GenesisCS Mini is made of materials that cause no activation during processing assuring the most viable product for application.  GenesisCS Mini can process your final product on the surgical field after centrifugation.  This single feature eliminates transfer contamination which can occur when the circulating nurse transfers plasma cell concentrate from a syringe into a sterile specimen cup on the surgical field.  This feature also allow the components to remain separated out in the blood, in its native pH, until you are ready for application